Keyphrases
Liraglutide
100%
Heart Rate Variability
100%
Placebo-controlled
100%
Heart Rate
100%
Randomized Double-blind
100%
New-onset Type 2 Diabetes
25%
Glucagon-like
25%
Receptor Agonist
25%
A1 Receptor
25%
Overweight Patient
25%
Placebo
25%
NN Intervals
25%
Root Mean Square of Successive Differences (RMSSD)
25%
Metabolic Rate
12%
Low-frequency Power
12%
Patients with Coronary Artery Disease
12%
Stable Coronary Artery Disease
12%
Heart Rate Change
12%
Massive Weight Loss
12%
Regression Analysis
12%
Night-time Heart Rate
12%
Cardiovascular Mortality
12%
Paired Analysis
12%
24-h Holter Monitoring
12%
Diurnal Variation
12%
Metabolic Parameters
12%
Metformin
12%
Agricultural and Biological Sciences
Placebo
100%
Cross-over Studies
100%
Liraglutide
100%
Epicardial Coronary Arteries
28%
Agonist
28%
Glucagon-Like Peptide 1 Receptor
28%
Spine
14%
Cardiovascular System
14%
Circadian Rhythm
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Placebo
100%
Coronary Artery Disease
28%
Glucagon Like Peptide 1 Receptor Agonist
28%
Non Insulin Dependent Diabetes Mellitus
28%
Obesity
28%
Cardiovascular Mortality
14%
Metformin
14%
Immunology and Microbiology
Heart Rate Variability
100%
Glucagon-Like Peptide-1
33%
Coronary Artery
33%
Agonist
33%
Metabolic Rate
16%
Vertebral Column
16%
Circadian Rhythm
16%
Cardiovascular Mortality
16%
Parasympathetic Tone
16%
Veterinary Science and Veterinary Medicine
Biochemistry, Genetics and Molecular Biology